A 64-Year-Old Man Hospitalized for COVID-19 Pneumonia and Treated with Tocilizumab Who Developed Chronic Cavitary Pulmonary Aspergillosis

Adebola Oluwabusayo Adetiloye; Farhana Alladin; Rasha Alaameri; Julio C. Valencia-Manrique; Olurotimi Badero; Armeen Poor

doi:10.12659/AJCR.938359

16 March 2023 : Case report

A 64-Year-Old Man Hospitalized for COVID-19 Pneumonia and Treated with Tocilizumab Who Developed Chronic Cavitary Pulmonary Aspergillosis

Unusual or unexpected effect of treatment, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis), Rare coexistence of disease or pathology

DOI: 10.12659/AJCR.938359

Am J Case Rep 2023; 24:e938359

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

View HTML version

A 64-Year-Old Man Hospitalized for COVID-19 Pneumonia and Treated with Tocilizumab Who Developed Chronic Cavitary Pulmonary Aspergillosis

Export

Export Article Citation

Export file: The selected type of file is required

Content:

Share via email

Share method:

Content:

Preview:

Your Privacy